These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 20819492)

  • 21. Prognostic value of 18F-FDG uptake on positron emission tomography in patients with pathologic stage I non-small cell lung cancer.
    Um SW; Kim H; Koh WJ; Suh GY; Chung MP; Kwon OJ; Choi JY; Han J; Lee KS; Kim J
    J Thorac Oncol; 2009 Nov; 4(11):1331-6. PubMed ID: 19701106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic value of 18F-fluorodeoxyglucose uptake by using serial positron emission tomography and computed tomography in patients with stage III nonsmall cell lung cancer.
    Xu X; Yu J; Sun X; Yang G; Li K; Fu Z; Han A; Zheng J
    Am J Clin Oncol; 2008 Oct; 31(5):470-5. PubMed ID: 18838884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imaging of hypoxia with 18F-FAZA PET in patients with locally advanced non-small cell lung cancer treated with definitive chemoradiotherapy.
    Trinkaus ME; Blum R; Rischin D; Callahan J; Bressel M; Segard T; Roselt P; Eu P; Binns D; MacManus MP; Ball D; Hicks RJ
    J Med Imaging Radiat Oncol; 2013 Aug; 57(4):475-81. PubMed ID: 23870348
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Luan X; Huang Y; Gao S; Sun X; Wang S; Ma L; Teng X; Lu H; Yu J; Yuan S
    Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2336-2342. PubMed ID: 27631310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia imaging with [¹⁸F]HX4 PET in NSCLC patients: defining optimal imaging parameters.
    Zegers CM; van Elmpt W; Wierts R; Reymen B; Sharifi H; Öllers MC; Hoebers F; Troost EG; Wanders R; van Baardwijk A; Brans B; Eriksson J; Windhorst B; Mottaghy FM; De Ruysscher D; Lambin P
    Radiother Oncol; 2013 Oct; 109(1):58-64. PubMed ID: 24044790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Value of (18)F-FDG PET-CT in the preoperative N staging of non-small cell lung cancer].
    Li M; Wu N; Liang Y; Zheng R; Liu Y; Zhang WJ; Zhao P
    Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):288-92. PubMed ID: 19615286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imaging of blood flow and hypoxia in head and neck cancer: initial evaluation with [(15)O]H(2)O and [(18)F]fluoroerythronitroimidazole PET.
    Lehtiö K; Oikonen V; Grönroos T; Eskola O; Kalliokoski K; Bergman J; Solin O; Grénman R; Nuutila P; Minn H
    J Nucl Med; 2001 Nov; 42(11):1643-52. PubMed ID: 11696633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxia imaging of uterine cervix carcinoma with (18)F-FETNIM PET/CT.
    Vercellino L; Groheux D; Thoury A; Delord M; Schlageter MH; Delpech Y; Barré E; Baruch-Hennequin V; Tylski P; Homyrda L; Walker F; Barranger E; Hindié E
    Clin Nucl Med; 2012 Nov; 37(11):1065-8. PubMed ID: 22996235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of preoperative positron emission tomography in resected stage I non-small cell lung cancer.
    Goodgame B; Pillot GA; Yang Z; Shriki J; Meyers BF; Zoole J; Gao F; Dehdashti F; Patterson A; Siegel BA; Govindan R
    J Thorac Oncol; 2008 Feb; 3(2):130-4. PubMed ID: 18303432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between 18F-fluoro-2-deoxy-D-glucose uptake values and tumor vitality: prognostic value of positron emission tomography in early-stage non-small cell lung cancer.
    Dooms C; van Baardwijk A; Verbeken E; van Suylen RJ; Stroobants S; De Ruysscher D; Vansteenkiste J
    J Thorac Oncol; 2009 Jul; 4(7):822-8. PubMed ID: 19487964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.
    Ashamalla H; Rafla S; Parikh K; Mokhtar B; Goswami G; Kambam S; Abdel-Dayem H; Guirguis A; Ross P; Evola A
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1016-23. PubMed ID: 15979817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repeatability of hypoxia PET imaging using [¹⁸F]HX4 in lung and head and neck cancer patients: a prospective multicenter trial.
    Zegers CM; van Elmpt W; Szardenings K; Kolb H; Waxman A; Subramaniam RM; Moon DH; Brunetti JC; Srinivas SM; Lambin P; Chien D
    Eur J Nucl Med Mol Imaging; 2015 Nov; 42(12):1840-9. PubMed ID: 26136164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour hypoxia imaging with 18F-fluoroazomycinarabinofuranoside PET/CT in patients with locally advanced rectal cancer.
    Havelund BM; Holdgaard PC; Rafaelsen SR; Mortensen LS; Theil J; Bender D; Pløen J; Spindler KL; Jakobsen A
    Nucl Med Commun; 2013 Feb; 34(2):155-61. PubMed ID: 23196674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of SUVmax measurements obtained by FDG-PET in patients with non-small cell lung cancer receiving chemotherapy.
    Imamura Y; Azuma K; Kurata S; Hattori S; Sasada T; Kinoshita T; Okamoto M; Kawayama T; Kaida H; Ishibashi M; Aizawa H
    Lung Cancer; 2011 Jan; 71(1):49-54. PubMed ID: 20430470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of hypoxia as measured by fluorine-18 fluoroerythronitroimidazole (
    Hu M; Zhu Y; Mu D; Fan B; Zhao S; Yang G; Ma L; Zheng J; Yu J
    Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1427-1434. PubMed ID: 31776634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of FDG uptake in early stage non-small cell lung cancer.
    Hanin FX; Lonneux M; Cornet J; Noirhomme P; Coulon C; Distexhe J; Poncelet AJ
    Eur J Cardiothorac Surg; 2008 May; 33(5):819-23. PubMed ID: 18374589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Significance of dual-time-point 18F-FDG PET imaging in evaluation of hilar and mediastinal lymph node metastasis in non-small-cell lung cancer].
    Hu M; Yu JM; Liu NB; Liu LP; Guo HB; Yang GR; Zhang PL; Xu XQ
    Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):306-9. PubMed ID: 18788639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy.
    Eschmann SM; Paulsen F; Reimold M; Dittmann H; Welz S; Reischl G; Machulla HJ; Bares R
    J Nucl Med; 2005 Feb; 46(2):253-60. PubMed ID: 15695784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between primary lesion FDG uptake and clinical stage at PET-CT for non-small cell lung cancer patients: An observation.
    Li M; Sun Y; Liu Y; Han A; Zhao S; Ma L; Zheng J; Yu J
    Lung Cancer; 2010 Jun; 68(3):394-7. PubMed ID: 19683358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single 20-second acquisition of deep-inspiration breath-hold PET/CT: clinical feasibility for lung cancer.
    Torizuka T; Tanizaki Y; Kanno T; Futatsubashi M; Yoshikawa E; Okada H; Ouchi Y
    J Nucl Med; 2009 Oct; 50(10):1579-84. PubMed ID: 19759111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.